Abstract
There are several concerns regarding surgical revascularization for Kawasaki coronary disease, including the choice of conduit, optimal timing, and indications for coronary artery bypass grafting (CABG). The internal thoracic artery is the best conduit for pediatric CABG because of its favorable growth potential and long-term patency. Use of a saphenous vein graft should be avoided unless the internal thoracic artery is unavailable. Indications for CABG for Kawasaki coronary disease have not yet been established. In principle, coronary aneurysms should be observed continuously for 1–2 years under restrictive anticoagulation therapy, because coronary aneurysms regress in 50 % of patients within 1–2 years. Presence of severe ischemia with giant coronary aneurysms involving obstructive lesions of the left main trunk or left anterior descending artery (LAD) is an unequivocal indication for CABG. In addition, a giant aneurysm with recurrent thrombosis under restrictive anticoagulation therapy or with severely delayed flow without significant localized stenosis may be an indication for CABG. However, determining surgical indications is difficult, especially for younger children, because of technical challenges. To prevent fatal complications, CABG might be indicated at a young age for patients with severe ischemia, because a history of myocardial infarction and impaired cardiac function affect prognosis. Down-sizing operation for giant aneurysms of non-LAD lesions without significant stenosis and severe calcification may be a good choice to improve coronary circulation and allow discontinuation of warfarin, if indications for this procedure can be established.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kitamura S, Kawashima Y, Fujita T, Mori T, Oyama C. Aortocoronary bypass grafting in a child with coronary artery obstruction due to mucocutaneous lymphnode syndrome: report of a case. Circulation. 1976;53(6):1035–40. http://dx.doi.org/10.1161/01.CIR.53.6.1035. PMID:1083781.
Kitamura S, Kawachi K, Oyama C, Miyagi Y, Morita R, Koh Y, et al. Severe Kawasaki heart disease treated with an internal mammary artery graft in pediatric patients. A first successful report. J Thorac Cardiovasc Surg. 1985;89(6):860–6. PMID:3873581.
Kitamura S, Tsuda E, Kobayashi J, Nakajima H, Yoshikawa Y, Yagihara T, et al. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation. 2009;120(1):60–8. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.840603, PMID:19546384.
Kitamura S, Kameda Y, Seki T, Kawachi K, Endo M, Takeuchi Y, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg. 1994;107(3):663–73. PMID:8127095.
Kitamura S. The role of coronary bypass operation on children with Kawasaki disease. Coron Artery Dis. 2002;13(8):437–47. http://dx.doi.org/10.1097/00019501-200212000-00009. PMID:12544719.
Yoshikawa Y, Yagihara T, Kameda Y, Taniguchi S, Tsuda E, Kawahira Y, et al. Result of surgical treatments in patients with coronary-arterial obstructive disease after Kawasaki disease. Eur J Cardiothorac Surg. 2000;17(5):515–9. http://dx.doi.org/10.1016/S1010-7940(00)00355-9. PMID:10814912.
Tsuda E, Kitamura S, Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation. 2004;110(11 Suppl 1):II61–6. PMID:15364840.
Kitamura S, Seki T, Kawachi K, Morita R, Kawata T, Mizuguchi K, et al. Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a “live” conduit. Circulation. 1988;78(3 Pt 2):I129–39. PMID:3261649.
He GW. Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice. Ann Thorac Surg. 1999;67:277–84.
Kitamura S, Kawachi K, Seki T, Morita R, Nishii T, Mizuguchi K, et al. Bilateral internal mammary artery grafts for coronary artery bypass operations in children. J Thorac Cardiovasc Surg. 1990;99(4):708–15. PMID:2319795.
Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg. 1999;117(5):855–72. http://dx.doi.org/10.1016/S0022-5223(99)70365-X. PMID:10220677.
Ochi M, Hatori N, Bessho R, Fujii M, Saji Y, Tanaka S, et al. Adequacy of flow capacity of bilateral internal thoracic artery T graft. Ann Thorac Surg. 2001;72(6):2008–11. http://dx.doi.org/10.1016/S0003-4975(01)03201-5. PMID:11789785.
Nakajima H, Kobayashi J, Toda K, Fujita T, Shimahara Y, Kasahara Y, et al. A 10-year angiographic follow-up of competitive flow in sequential and composite arterial grafts. Eur J Cardiothorac Surg. 2011;40(2):399–404. PMID:21236696.
Tsuda E, Fujita H, Yagihara T, Yamada O, Echigo S, Kitamura S. Competition between native flow and graft flow after coronary artery bypass grafting. Impact on indications for coronary artery bypass grafting for localized stenosis with giant aneurysms due to Kawasaki disease. Pediatr Cardiol. 2008;29(2):266–70. http://dx.doi.org/10.1007/s00246-007-9114-y. PMID:17917764.
Takeuchi Y, Gomi A, Okamura Y, Mori H, Nagashima M. Coronary revascularization in a child with Kawasaki disease: use of right gastroepiploic artery. Ann Thorac Surg. 1990;50(2):294–6. http://dx.doi.org/10.1016/0003-4975(90)90754-T. PMID:2383118.
JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)—digest version. Circ J. 2010;74(9):1989–2020. http://dx.doi.org/10.1253/circj.CJ-10-74-0903. PMID:20724794.
Subcommittee of Cardiovascular Sequelae SoST, Kawasaki Disease Research Committee. Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease. Heart Vessels 1987;3(1):50–4. http://dx.doi.org/10.1007/BF02073648. PMID:3624163
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al.; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic fever, Endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 2004;110(17):2747–71. http://dx.doi.org/10.1161/01.CIR.0000145143.19711.78. PMID:15505111
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–85. http://dx.doi.org/10.1161/01.CIR.94.6.1379. PMID:8822996.
Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol. 1985;56(13):846–51. http://dx.doi.org/10.1016/0002-9149(85)90767-2. PMID:4061324.
Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 1994;74(8):822–4. http://dx.doi.org/10.1016/0002-9149(94)90446-4. PMID:7942561.
Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr. 1986;108(6):923–7. http://dx.doi.org/10.1016/S0022-3476(86)80928-3. PMID:3712157.
Suzuki A, Kamiya T, Ono Y, Takahashi N, Naito Y, Kou Y. Indication of aortocoronary by-pass for coronary arterial obstruction due to Kawasaki disease. Heart Vessels. 1985;1(2):94–100. http://dx.doi.org/10.1007/BF02066356. PMID:3879490.
Suzuki A, Kamiya T, Ono Y, Kinoshita Y, Kawamura S, Kimura K. Clinical significance of morphologic classification of coronary arterial segmental stenosis due to Kawasaki disease. Am J Cardiol. 1993;71(13):1169–73. http://dx.doi.org/10.1016/0002-9149(93)90641-O. PMID:8480642.
Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, Uchikoba Y, et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol. 2004;43(4):653–61. http://dx.doi.org/10.1016/j.jacc.2003.10.032. PMID:14975478.
Ogawa S, Fukazawa R, Ohkubo T, Zhang J, Takechi N, Kuramochi Y, et al. Silent myocardial ischemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation. 1997;96(10):3384–9. http://dx.doi.org/10.1161/01.CIR.96.10.3384. PMID:9396431.
Yamauchi H, Ochi M, Fujii M, Hinokiyama K, Ohmori H, Sasaki T, et al. Optimal time of surgical treatment for Kawasaki coronary artery disease. J Nippon Med Sch. 2004;71(4):279–86. http://dx.doi.org/10.1272/jnms.71.279. PMID:15329488.
Tsuda E, Kitamura S, Kimura K, Kobayashi J, Miyazaki S, Echigo S, et al. Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children. Am Heart J. 2007;153(6):995–1000. http://dx.doi.org/10.1016/j.ahj.2007.03.034. PMID:17540201.
Mavroudis C, Backer CL, Muster AJ, Pahl E, Sanders JH, Zales VR, et al. Expanding indications for pediatric coronary artery bypass. J Thorac Cardiovasc Surg. 1996;111(1):181–9. http://dx.doi.org/10.1016/S0022-5223(96)70415-4. PMID:8551764.
Fortune RL, Baron PJ, Fitzgerald JW. Atresia of the left main coronary artery: repair with left internal mammary artery bypass. J Thorac Cardiovasc Surg. 1987;94(1):150–1. PMID:3496498.
Ohkubo T, Fukazawa R, Ikegami E, Ogawa S. Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations. Pediatr Int. 2007;49(1):1–7. http://dx.doi.org/10.1111/j.1442-200X.2007.02312.x. PMID:17250496.
Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int. 2000;42(5):470–5. http://dx.doi.org/10.1046/j.1442-200x.2000.01270.x. PMID:11059533.
Hamaoka K, Onouchi Z. Effects of coronary artery aneurysms on intracoronary flow velocity dynamics in Kawasaki disease. Am J Cardiol. 1996;77(10):873–5. http://dx.doi.org/10.1016/S0002-9149(97)89186-2. PMID:8623744.
Suda K, Kudo Y, Higaki T, Nomura Y, Miura M, Matsumura M, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J. 2009;73(7):1319–23. http://dx.doi.org/10.1253/circj.CJ-08-0931. PMID:19436123.
Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29(2):398–401. http://dx.doi.org/10.1007/s00246-007-9132-9. PMID:18027010.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan
About this chapter
Cite this chapter
Maruyama, Y., Ochi, M. (2017). Long-Term Outcomes of Pediatric Coronary Artery Bypass Grafting and Down-Sizing Operation for Giant Coronary Aneurysms. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_42
Download citation
DOI: https://doi.org/10.1007/978-4-431-56039-5_42
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56037-1
Online ISBN: 978-4-431-56039-5
eBook Packages: MedicineMedicine (R0)